vs

Side-by-side financial comparison of NATURAL GAS SERVICES GROUP INC (NGS) and RECURSION PHARMACEUTICALS, INC. (RXRX). Click either name above to swap in a different company.

NATURAL GAS SERVICES GROUP INC is the larger business by last-quarter revenue ($46.1M vs $35.5M, roughly 1.3× RECURSION PHARMACEUTICALS, INC.). NATURAL GAS SERVICES GROUP INC runs the higher net margin — 8.9% vs -304.2%, a 313.1% gap on every dollar of revenue. On growth, RECURSION PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (681.7% vs 13.5%). NATURAL GAS SERVICES GROUP INC produced more free cash flow last quarter ($-20.7M vs $-47.3M).

Southern Company Gas, formerly AGL Resources, is an American Fortune 500 energy services holding company headquartered in Atlanta, Georgia. The company's operations consist of natural gas distribution, wholesale services, retail operations, and midstream operations. Southern Company Gas is one of the largest natural gas distribution companies in the United States. The company serves approximately 4.5 million utility customers through its regulated distribution subsidiaries across four states....

Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines artificial intelligence and large-scale high-throughput biological experimentation to discover and develop innovative therapies for rare diseases, oncology, inflammatory disorders, and other areas of unmet medical need. It primarily operates in North America and partners with global biopharmaceutical firms to advance its robust therapeutic pipeline.

NGS vs RXRX — Head-to-Head

Bigger by revenue
NGS
NGS
1.3× larger
NGS
$46.1M
$35.5M
RXRX
Growing faster (revenue YoY)
RXRX
RXRX
+668.2% gap
RXRX
681.7%
13.5%
NGS
Higher net margin
NGS
NGS
313.1% more per $
NGS
8.9%
-304.2%
RXRX
More free cash flow
NGS
NGS
$26.6M more FCF
NGS
$-20.7M
$-47.3M
RXRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NGS
NGS
RXRX
RXRX
Revenue
$46.1M
$35.5M
Net Profit
$4.1M
$-108.1M
Gross Margin
59.8%
Operating Margin
15.4%
-304.8%
Net Margin
8.9%
-304.2%
Revenue YoY
13.5%
681.7%
Net Profit YoY
43.2%
39.6%
EPS (diluted)
$0.32
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NGS
NGS
RXRX
RXRX
Q4 25
$46.1M
$35.5M
Q3 25
$43.4M
$5.2M
Q2 25
$41.4M
$19.2M
Q1 25
$41.4M
$14.7M
Q4 24
$40.7M
$4.5M
Q3 24
$26.1M
Q2 24
$14.4M
Q1 24
$13.8M
Net Profit
NGS
NGS
RXRX
RXRX
Q4 25
$4.1M
$-108.1M
Q3 25
$5.8M
$-162.3M
Q2 25
$5.2M
$-171.9M
Q1 25
$4.9M
$-202.5M
Q4 24
$2.9M
$-178.9M
Q3 24
$-95.8M
Q2 24
$-97.5M
Q1 24
$-91.4M
Gross Margin
NGS
NGS
RXRX
RXRX
Q4 25
59.8%
Q3 25
-183.8%
Q2 25
-4.9%
Q1 25
-48.0%
Q4 24
-181.4%
Q3 24
53.7%
Q2 24
36.2%
Q1 24
19.1%
Operating Margin
NGS
NGS
RXRX
RXRX
Q4 25
15.4%
-304.8%
Q3 25
24.8%
-3327.6%
Q2 25
24.0%
-916.8%
Q1 25
23.0%
-1297.9%
Q4 24
14.9%
-4042.4%
Q3 24
-377.1%
Q2 24
-697.4%
Q1 24
-698.4%
Net Margin
NGS
NGS
RXRX
RXRX
Q4 25
8.9%
-304.2%
Q3 25
13.3%
-3135.3%
Q2 25
12.5%
-894.2%
Q1 25
11.7%
-1373.3%
Q4 24
7.0%
-3935.5%
Q3 24
-367.5%
Q2 24
-676.6%
Q1 24
-662.4%
EPS (diluted)
NGS
NGS
RXRX
RXRX
Q4 25
$0.32
$-0.17
Q3 25
$0.46
$-0.36
Q2 25
$0.41
$-0.41
Q1 25
$0.38
$-0.50
Q4 24
$0.22
$-0.56
Q3 24
$-0.34
Q2 24
$-0.40
Q1 24
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NGS
NGS
RXRX
RXRX
Cash + ST InvestmentsLiquidity on hand
$743.3M
Total DebtLower is stronger
$9.6M
Stockholders' EquityBook value
$274.7M
$1.1B
Total Assets
$586.8M
$1.5B
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NGS
NGS
RXRX
RXRX
Q4 25
$743.3M
Q3 25
$659.8M
Q2 25
$325.0K
$525.1M
Q1 25
$2.1M
$500.5M
Q4 24
$2.1M
$594.4M
Q3 24
$427.6M
Q2 24
$474.3M
Q1 24
$296.3M
Total Debt
NGS
NGS
RXRX
RXRX
Q4 25
$9.6M
Q3 25
$11.9M
Q2 25
$14.2M
Q1 25
$16.4M
Q4 24
$19.0M
Q3 24
$20.5M
Q2 24
$22.9M
Q1 24
Stockholders' Equity
NGS
NGS
RXRX
RXRX
Q4 25
$274.7M
$1.1B
Q3 25
$271.4M
$1.0B
Q2 25
$266.2M
$919.1M
Q1 25
$260.3M
$933.9M
Q4 24
$255.1M
$1.0B
Q3 24
$524.6M
Q2 24
$584.4M
Q1 24
$401.2M
Total Assets
NGS
NGS
RXRX
RXRX
Q4 25
$586.8M
$1.5B
Q3 25
$562.3M
$1.4B
Q2 25
$525.5M
$1.3B
Q1 25
$501.7M
$1.3B
Q4 24
$492.5M
$1.4B
Q3 24
$726.5M
Q2 24
$775.9M
Q1 24
$557.8M
Debt / Equity
NGS
NGS
RXRX
RXRX
Q4 25
0.01×
Q3 25
0.01×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.04×
Q2 24
0.04×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NGS
NGS
RXRX
RXRX
Operating Cash FlowLast quarter
$13.9M
$-46.1M
Free Cash FlowOCF − Capex
$-20.7M
$-47.3M
FCF MarginFCF / Revenue
-44.8%
-133.1%
Capex IntensityCapex / Revenue
74.9%
3.5%
Cash ConversionOCF / Net Profit
3.38×
TTM Free Cash FlowTrailing 4 quarters
$-58.6M
$-378.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NGS
NGS
RXRX
RXRX
Q4 25
$13.9M
$-46.1M
Q3 25
$16.8M
$-117.4M
Q2 25
$11.0M
$-76.4M
Q1 25
$21.3M
$-132.0M
Q4 24
$9.4M
$-115.4M
Q3 24
$-59.2M
Q2 24
$-82.2M
Q1 24
$-102.3M
Free Cash Flow
NGS
NGS
RXRX
RXRX
Q4 25
$-20.7M
$-47.3M
Q3 25
$-25.1M
$-117.6M
Q2 25
$-14.8M
$-79.6M
Q1 25
$2.0M
$-133.8M
Q4 24
$-5.1M
$-116.7M
Q3 24
$-63.8M
Q2 24
$-83.4M
Q1 24
$-109.0M
FCF Margin
NGS
NGS
RXRX
RXRX
Q4 25
-44.8%
-133.1%
Q3 25
-57.7%
-2272.5%
Q2 25
-35.8%
-413.9%
Q1 25
4.9%
-907.4%
Q4 24
-12.6%
-2567.7%
Q3 24
-244.6%
Q2 24
-578.5%
Q1 24
-789.9%
Capex Intensity
NGS
NGS
RXRX
RXRX
Q4 25
74.9%
3.5%
Q3 25
96.5%
4.7%
Q2 25
62.4%
16.4%
Q1 25
46.5%
12.4%
Q4 24
35.8%
28.6%
Q3 24
17.5%
Q2 24
8.2%
Q1 24
48.2%
Cash Conversion
NGS
NGS
RXRX
RXRX
Q4 25
3.38×
Q3 25
2.90×
Q2 25
2.12×
Q1 25
4.38×
Q4 24
3.29×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons